These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 1474775)
1. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Pereira BJ; Poutsiaka DD; King AJ; Strom JA; Narayan G; Levey AS; Dinarello CA Kidney Int; 1992 Dec; 42(6):1419-24. PubMed ID: 1474775 [TBL] [Abstract][Full Text] [Related]
2. Increased production of interleukin-1beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure. Higuchi T; Yamamoto C; Kuno T; Mizuno M; Takahashi S; Kanmatsuse K Nephron; 1997; 76(1):26-31. PubMed ID: 9171296 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Pereira BJ; Shapiro L; King AJ; Falagas ME; Strom JA; Dinarello CA Kidney Int; 1994 Mar; 45(3):890-6. PubMed ID: 8196293 [TBL] [Abstract][Full Text] [Related]
4. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115 [TBL] [Abstract][Full Text] [Related]
5. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Gu Y; Ding F; Qin H; Zhao H; Lin S Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226 [TBL] [Abstract][Full Text] [Related]
6. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells. Linnenweber S; Lonnemann G Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients. Balakrishnan VS; Jaber BL; Natov SN; Cendoroglo M; King AJ; Schmid CH; Pereira BJ Kidney Int; 1998 Dec; 54(6):2106-12. PubMed ID: 9853276 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production. Pereira BJ; King AJ; Falagas ME; Dinarello CA Nephron; 1994; 67(3):358-61. PubMed ID: 7936030 [TBL] [Abstract][Full Text] [Related]
9. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions. Powell AC; Bland LE; Oettinger CW; McAllister SK; Oliver JC; Arduino MJ; Favero MS J Am Soc Nephrol; 1991 Nov; 2(5):1007-13. PubMed ID: 1760536 [TBL] [Abstract][Full Text] [Related]
10. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients. McKenna RM; Macdonald C; Bernstein KN; Rush DN Nephron; 1994; 67(2):190-6. PubMed ID: 8072608 [TBL] [Abstract][Full Text] [Related]
11. The influence of uremic serum on interleukin-1beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells. Higuchi T; Fukuda N; Yamamoto C; Yamazaki T; Oikawa O; Ohnishi Y; Okada K; Soma M; Matsumoto K Ther Apher Dial; 2006 Feb; 10(1):65-71. PubMed ID: 16556139 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [TBL] [Abstract][Full Text] [Related]
13. Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells. Pereira BJ; King AJ; Poutsiaka DD; Strom JA; Dinarello CA Am J Kidney Dis; 1993 Aug; 22(2):288-95. PubMed ID: 8352255 [TBL] [Abstract][Full Text] [Related]
14. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels. Anderson J; Briefel G; Jones JM; Ryu JH; McGuire M; Yun YP Kidney Int; 1991 Dec; 40(6):1110-7. PubMed ID: 1762311 [TBL] [Abstract][Full Text] [Related]
15. Cytokine production in patients on dialysis. Pereira BJ Blood Purif; 1995; 13(3-4):135-46. PubMed ID: 7619385 [TBL] [Abstract][Full Text] [Related]
16. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891 [TBL] [Abstract][Full Text] [Related]
17. Cytokine production by mononuclear cells from patients with chronic renal failure. Weinstein T; Fishman P; Djaldetti M; Levi J Isr J Med Sci; 1993 Apr; 29(4):183-6. PubMed ID: 8491567 [TBL] [Abstract][Full Text] [Related]
18. Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells. Higuchi T; Kuno T; Takahashi S; Kanmatsuse K Artif Organs; 1997 Apr; 21(4):265-71. PubMed ID: 9096797 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation. Libetta C; De Nicola L; Rampino T; De Simone W; Memoli B Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837 [TBL] [Abstract][Full Text] [Related]
20. Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients. Perianayagam MC; Jaber BL; Guo D; King AJ; Pereira BJ; Balakrishnan VS Blood Purif; 2002; 20(6):543-50. PubMed ID: 12566670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]